August 26, 2021
MGC Pharmaceuticals in its first USA supply agreement for its phytocannabinoid products
MGC Pharmaceuticals, a specialist in phytocannabinoid-derived medicines, has signed a binding US Market Supply and Distribution Agreement with US-based AMC Holdings, with minimum orders of $24 million for MGC products including CannEpil®, CogniCann® and CimetrA™ over the initial 3 year period.